US Doctor Anthony Fauci Hopeful over Coronavirus Vaccine Development by the End of 2020

America's top infectious disease specialist, Dr. Anthony Fauci, is very optimistic about the development of the coronavirus vaccine.
US Doctor Anthony Fauci Hopeful over Coronavirus Vaccine Development by the End of 2020
Updated on

America's top infectious disease specialist, Dr. Anthony Fauci, is very optimistic about the development of the coronavirus vaccine. He has stated that he is awaiting the results of the ongoing human trials of the coronavirus vaccine. Dr. Fauci further said that he is hopeful for the development of the vaccine by the end of this year.

He said that he is cautiously optimistic about all these possibilities. Dr. Fauci, director of the National Institute of Allergy and Infectious Diseases, said the coronavirus will likely continue to emerge and global cooperation and transparency are critical to deal with future epidemics.

Good public health measures are important to control this epidemic: Dr. Fauci

He further said that the lesson we have learned from the coronavirus is that it has pandemic potential, it will likely continue to emerge. Good public health measures are important to control them. Global cooperation and transparency are important if we are to gain control of this extraordinary attack on the human population, a viral disease that spreads rapidly and has a high level of mortality. He said these things in his remarks during an online session on 'Convincing COVID-19 Through Innovation and Research: Lessons Learned from the Pandemic'.

Image credit: The Financial Express
Image credit: The Financial Express

We have adopted a strategic approach: Dr. Fauci

The event is part of a series of online dialogues by '75: 75 Minutes of Conversation' by UN Academic Impact (UNAI), which brings UN academics, researchers and students from all over the world. Observing the epidemic and efforts to develop the corona vaccine, Fauci said that we have adopted a strategic approach to get multiple candidates and there are more than one candidate vaccine to be conducted in trials in a harmonized way so that we use standard endpoints, standard endpoints and single data and safety monitoring boards, as well as similar immunological parameters, so you can bridge one study to another.

Like and Follow us on :

Related Stories

No stories found.
logo
Since independence
www.sinceindependence.com